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Background:  There is a higher incidence of stroke in patients with hypertensive as well as prehypertensive blood pressure (BP) levels compared 
to normotensive individuals. While several studies have proven that that long-term BP reduction in hypertensive patients reduces the incidence 
of cardiovascular events including stroke, it is still not known whether treatment of prehypertensive BP levels has in a similar effect. We sought to 
determine whether reduction in BP in the prehypertensive range reduces the incidence of stroke by performing a meta-analysis of randomized trials 
comparing an anti-hypertensive drug against placebo in cohorts with prehypertensive baseline BP levels.
Methods:  95 different anti-hypertensive agents were included in a systematic search of MEDLINE returning a total of 2,852 results. Trials involving 
specific conditions in which certain anti-hypertensive drugs are known to exert clinical benefit through mechanisms not necessarily related to BP 
reduction were excluded.
Findings: A total of 19 trials involving 72,573 patients were included. Patients randomized to the active treatment arm had a statistically highly 
significant reduction in the risk of stroke compared to control patients (RR 0.80, [95% CI 0.72 to 0.88], p=0.00001) (Figure).
Interpretation: This meta-analysis shows that the risk of stroke is highly significantly reduced with anti-hypertensive therapy in patients with 
baseline BP <140/90 mm Hg. These findings have important clinical implications. 
